CHENGZHI(SZ:000990) Shang Hai Zheng Quan Bao·2025-10-24 18:56Core Viewpoint - The company emphasizes the accuracy and completeness of its quarterly financial report, asserting that there are no false records or misleading statements [2][3]. Financial Data Summary - The third-quarter financial report has not been audited [3][12]. - The company does not require retrospective adjustments or restatements of previous accounting data [3]. - There are no non-recurring profit and loss items applicable for this quarter [3]. Changes in Financial Indicators - The company has provided explanations for changes in the balance sheet, income statement, and cash flow statement, although specific details are not disclosed in the provided documents [4][5]. Shareholder Information - The company has not reported any changes in the top ten shareholders or significant shareholders due to securities lending activities [5][7]. Other Important Matters - The company is in the process of establishing a health insurance company with a planned registered capital of 1 billion yuan, but there has been no progress reported as of the current period [5]. - The company is advancing its investment projects in Qingdao, including the POE project and ultra-high molecular weight polyethylene project, with ongoing procurement and construction activities [6]. - The company is preparing for the IPO of its subsidiary, Chengzhi Yonghua, and is actively engaging with regulatory bodies [8]. - A total investment of 350 million yuan is planned for a multifunctional workshop and raw material drug workshop project in Jiangxi, with construction progressing [9]. - The company has reached an agreement regarding debt recovery from Wansheng Bio, with a total claim of approximately 133.18 million yuan [10]. - The company is also investing in a high-performance liquid crystal materials upgrade project, with various preparatory works completed [11].